BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3646103)

  • 1. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects.
    Youngberg CA; Berardi RR; Howatt WF; Hyneck ML; Amidon GL; Meyer JH; Dressman JB
    Dig Dis Sci; 1987 May; 32(5):472-80. PubMed ID: 3646103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Comparison of Physical Parameters, Enzyme Activity, Acid Resistance, and pH Dissolution Characteristics of Enteric-Coated Pancreatic Enzyme Preparations: Implications for Clinical Variability and Pharmacy Substitution.
    Kuhn RJ; Eyting S; Henniges F; Potthoff A
    J Pediatr Pharmacol Ther; 2007 Apr; 12(2):115-28. PubMed ID: 23055848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An
    Barrack KE; Hampton TH; Valls RA; Surve SV; Gardner TB; Sanville JL; Madan JL; O'Toole GA
    J Bacteriol; 2024 Jan; 206(1):e0028623. PubMed ID: 38169295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in Permeability Assessment for Oral Drug Product Development.
    Koziolek M; Augustijns P; Berger C; Cristofoletti R; Dahlgren D; Keemink J; Matsson P; McCartney F; Metzger M; Mezler M; Niessen J; Polli JE; Vertzoni M; Weitschies W; Dressman J
    Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(curcumin β-amino ester)-Based Tablet Formulation for a Sustained Release of Curcumin.
    Patil VS; Burdette BC; Hilt JZ; Kalika DS; Dziubla TD
    Gels; 2022 May; 8(6):. PubMed ID: 35735681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis.
    Freswick PN; Reid EK; Mascarenhas MR
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of Neusilin
    Bílik T; Vysloužil J; Naiserová M; Muselík J; Pavelková M; Mašek J; Čopová D; Čulen M; Kubová K
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut-Lung Axis in Cystic Fibrosis.
    Price CE; O'Toole GA
    J Bacteriol; 2021 Sep; 203(20):e0031121. PubMed ID: 34339302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline in cystic fibrosis: relations to pancreas insufficiency, enterohepatic cycle, PEMT and intestinal microbiota.
    Bernhard W
    Eur J Nutr; 2021 Jun; 60(4):1737-1759. PubMed ID: 32797252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A first approach for an evidence-based in vitro digestion method to adjust pancreatic enzyme replacement therapy in cystic fibrosis.
    Calvo-Lerma J; Fornés-Ferrer V; Peinado I; Heredia A; Ribes-Koninckx C; Andrés A
    PLoS One; 2019; 14(2):e0212459. PubMed ID: 30794618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial bile acid levels in intestine and plasma reveal altered biliary circulation in chronic pancreatitis patients.
    Humbert L; Rainteau D; Tuvignon N; Wolf C; Seksik P; Laugier R; Carrière F
    J Lipid Res; 2018 Nov; 59(11):2202-2213. PubMed ID: 30206181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pH.
    Abuhelwa AY; Foster DJR; Upton RN
    AAPS J; 2016 Sep; 18(5):1309-1321. PubMed ID: 27495120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Quantitative Review and Meta-models of the Variability and Factors Affecting Oral Drug Absorption-Part II: Gastrointestinal Transit Time.
    Abuhelwa AY; Foster DJR; Upton RN
    AAPS J; 2016 Sep; 18(5):1322-1333. PubMed ID: 27439620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wireless telemetry and cystic fibrosis: just the pHacts.
    Kaunitz JD; Akiba Y
    Dig Dis Sci; 2013 Aug; 58(8):2129-30. PubMed ID: 23748712
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulated traffic of anion transporters in mammalian Brunner's glands: a role for water and fluid transport.
    Collaco AM; Jakab RL; Hoekstra NE; Mitchell KA; Brooks A; Ameen NA
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(3):G258-75. PubMed ID: 23744739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-specific effects of luminal acid, bicarbonate, cAMP, and carbachol on transporter trafficking in the intestine.
    Jakab RL; Collaco AM; Ameen NA
    Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(8):G937-50. PubMed ID: 22936272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal pH and gastrointestinal transit profiles in cystic fibrosis patients measured by wireless motility capsule.
    Gelfond D; Ma C; Semler J; Borowitz D
    Dig Dis Sci; 2013 Aug; 58(8):2275-81. PubMed ID: 22592630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological parameters for oral delivery and in vitro testing.
    Mudie DM; Amidon GL; Amidon GE
    Mol Pharm; 2010 Oct; 7(5):1388-405. PubMed ID: 20822152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of biorelevant dissolution media to forecast the in vivo performance of a drug.
    Klein S
    AAPS J; 2010 Sep; 12(3):397-406. PubMed ID: 20458565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular bicarbonate protects rat duodenal mucosa from acid-induced injury.
    Akiba Y; Furukawa O; Guth PH; Engel E; Nastaskin I; Sassani P; Dukkipatis R; Pushkin A; Kurtz I; Kaunitz JD
    J Clin Invest; 2001 Dec; 108(12):1807-16. PubMed ID: 11748264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.